Request for Offers No. 33/2019 – IBD/IPF/YKL40/ARG

The order carried out as a part of the projects titled:

IBD: „PRE-CLINICAL AND CLINICAL RESEARCH OF CANDIDATE FOR INNOVATIVE DRUG IN ASTHMA AND INFLAMMATORY BOWEL DISEASES THERAPY” (POIR.01.01.01 00-0168/15)
IPF: DEVELOPMENT OF A FIRST-IN-CLASS SMALL MOLECULE DRUG CANDIDATE FOR TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS THROUGH CHITOTRIOSIDASE INHIBITION (POIR.01.01.01-00-0551/15)
YKL-40: DEVELOPMENT OF A FIRST-IN-CLASS SMALL MOLECULE DRUG CANDIDATE FOR CANCER TREATMENT THROUGH YKL40 INHIBITION (POIR.01.01.01-00-0552/16)
ARG: „PRE-CLINICAL AND CLINICAL DEVELOPMENT OF ARGINASE INHBITOR FOR CANCER IMMUNOTHERAPY” (POIR.01.01.01-00-0415/17)

co-financed by the National and European Union Funds and because of the competitiveness principle. We hereby look for Contractor ready to perform the service:
In vitro toxicology research services aiming at the assessment of potential cardiotoxicity of 10 small molecule compounds in a cell-based assay on iPS-derived cardiomyocytes using the microelectrode array (MEA) within 18 months

Request fo offers 33_2019

Appendices to request 33_2019

MichałRequest for Offers No. 33/2019 – IBD/IPF/YKL40/ARG